Implementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications

Anaesthesia

Volumn 73, Issue 9, 2018, Pages 1067-1078

  Rudolph, M I ^a   Chitilian, H V ^a   Ng, P Y ^a,b   Timm, F P ^a   Agarwala, A V ^a   Doney, A B ^a   Ramachandran, S K ^a   Houle, T T ^c   Eikermann, M ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

neostigmine: dose rationale; neuromuscular block: assessment; patient care; quality measures

Indexed keywords

NEOSTIGMINE; CHOLINESTERASE INHIBITOR;

ADULT; ARTICLE; CLINICAL OUTCOME; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; LENGTH OF STAY; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NEUROMUSCULAR BLOCKING; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RISK FACTOR; TIME SERIES ANALYSIS; TOTAL QUALITY MANAGEMENT; AGED; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECT; ECONOMICS; HOSPITAL COST; LUNG DISEASE; MASSACHUSETTS; MIDDLE AGED; NEUROMUSCULAR JUNCTION; ORGANIZATION AND MANAGEMENT; PROCEDURES; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; LUNG DISEASES; MALE; MASSACHUSETTS; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT; YOUNG ADULT;

EID: 85050407180     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.14326     Document Type: Article

References (36)

1. Hunter JM. Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation. British Journal of Anaesthesia 2017; 119: i53–i62.
2. Naguib M, Brull SJ, Kopman AF, et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesthesia and Analgesia 2018; 127: 71–80.
3. Murphy GS, Szokol JW, Avram MJ, et al. Residual neuromuscular block in the elderly: incidence and clinical implications. Anesthesiology 2015; 123: 1322–36.
4. Fortier LP, McKeen D, Turner K, et al. The RECITE Study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesthesia and Analgesia 2015; 121: 366–72.
5. Esteves S, Martins M, Barros F, et al. Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: an observational multicentre study in Portugal. European Journal of Anaesthesiology 2013; 30: 243–9.
6. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ. Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesthesia and Analgesia 2008; 107: 130–7.
7. Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2009; 110: 1253–60.
8. Murphy GS, Szokol JW, Marymont JH, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109: 389–98.
9. Stewart PA, Liang SS, Li QS, et al. The impact of residual neuromuscular blockade, oversedation, and hypothermia on adverse respiratory events in a postanesthetic care unit: a prospective study of prevalence, predictors, and outcomes. Anesthesia and Analgesia 2016; 123: 859–68.
10. Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesthesia and Analgesia 2010; 111: 129–40.
11. Sasaki N, Meyer MJ, Malviya SA, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology 2014; 121: 959–68.
12. McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology 2015; 122: 1201–13.
13. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Annals of Internal Medicine 2007; 147: 573–7.
14. Grabitz SD, Farhan HN, Ruscic KJ, et al. Dose-dependent protective effect of inhalational anesthetics against postoperative respiratory complications: a prospective analysis of data on file from three hospitals in New England. Critical Care Medicine 2017; 45: e30–9.
15. Timm FP, Houle TT, Grabitz SD, et al. Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study. BMJ (Clinical Research ed.) 2017; 356: i6635.
16. Bagchi A, Rudolph MI, Ng PY, et al. The association of postoperative pulmonary complications in 109,360 patients with pressure-controlled or volume-controlled ventilation. Anaesthesia 2017; 72: 1334–43.
17. Shin CH, Long DR, McLean D, et al. Effects of Intraoperative fluid management on postoperative outcomes: a hospital registry study. Annals of Surgery 2018; 267: 1084–92.
18. Kopman AF, Eikermann M. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia 2009; 64(Suppl 1): 22–30.
19. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 2005; 43: 1130–9.
20. Brueckmann B, Villa-Uribe JL, Bateman BT, et al. Development and validation of a score for prediction of postoperative respiratory complications. Anesthesiology 2013; 118: 1276–85.
21. Dalton JE, Kurz A, Turan A, Mascha EJ, Sessler DI, Saager L. Development and validation of a risk quantification index for 30-day postoperative mortality and morbidity in noncardiac surgical patients. Anesthesiology 2011; 114: 1336–44.
22. Canet J, Gallart L, Gomar C, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 2010; 113: 1338–50.
23. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Statistical Methods in Medical Research 2007; 16: 219–42.
24. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research 2011; 46: 399–424.
25. Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Academic Pediatrics 2013; 13: S38–44.
26. Durbin J, Watson GS. Testing for serial correlation in least squares regression. I. Biometrika 1950; 37: 409–28.
27. Moore JA, Conway DH, Thomas N, Cummings D, Atkinson D. Impact of a peri-operative quality improvement programme on postoperative pulmonary complications. Anaesthesia 2017; 72: 317–27.
28. Todd MM, Hindman BJ, King BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesthesia and Analgesia 2014; 119: 323–31.
29. Todd MM, Hindman BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department: follow-up observations. Anesthesia and Analgesia 2015; 121: 836–8.
30. Baillard C, Clec'h C, Catineau J, et al. Postoperative residual neuromuscular block: a survey of management. British Journal of Anaesthesia 2005; 95: 622–6.
31. Johnson MJ, May CR. Promoting professional behaviour change in healthcare: what interventions work, and why? A theory-led overview of systematic reviews. British Medical Journal Open 2015; 5: e008592.
32. Mostofian F, Ruban C, Simunovic N, Bhandari M. Changing physician behavior: what works? American Journal of Managed Care 2015; 21: 75–84.
33. Ladha KS, Nanji KC, Pierce E, Poon KT, Hyder JA. The impact of a shortage of pharmacy-prepared ephedrine syringes on intraoperative medication use. Anesthesia and Analgesia 2015; 121: 404–9.
34. Murphy GS, Szokol JW, Avram MJ, et al. Neostigmine administration after spontaneous recovery to a train-of-four ratio of 0.9 to 1.0: a randomized controlled trial of the effect on neuromuscular and clinical recovery. Anesthesiology 2018; 128: 27–37.
35. Grimshaw JM, Eccles MP, Walker AE, Thomas RE. Changing physicians’ behavior: what works and thoughts on getting more things to work. Journal of Continuing Education in the Health Professions 2002; 22: 237–43.
36. Flodgren G, Eccles MP, Shepperd S, Scott A, Parmelli E, Beyer FR. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database of Systematic Reviews 2011; 6: CD009255.